when was semaglutide patented Patent Expiry in 2026: Why India Is On the Pharma Radar A Snapshot of the Semaglutide

2024 Feb 6;36(2):408-421.e5

Executive summary Among 1,482 adults with a body mass index (BMI) 27 kg/m2 who initiated injectable semaglutide between March 2018 and November 2023, the median percentage BMI reduction after 3-6 months was 4.5% (interquartile range: 1.8% to 8.3%)

The Avoid List: High-Calorie Additives Many popular coffee drinks, lattes, frappuccinos, and speciality beverages contain significant amounts of sugar, syrups, and high-fat creamers, which contribute calories and may negate the caloric deficit aimed for with Wegovy

Research involving animal models has shown that various antioxidants can effectively reduce the ototoxic effects of aminoglycosides and cisplatin without diminishing their therapeutic efficacy, thereby highlighting their promise as treatment options